You are here

drug pricing

Pharma stocks slide as industry mulls Trump drug price action

Biopharma Dive

Tue, 07/9/19 - 08:55 am

Federal judge blocks Trump rule to require drug prices in TV ads

Stat

Mon, 07/8/19 - 08:10 pm

Executive order under construction to peg US drug prices to lowest prices abroad, Trump says

Endpoints

Mon, 07/8/19 - 10:26 am

Trump plans drug pricing executive order aimed at ensuring U.S. pays less than other nations

Stat

Fri, 07/5/19 - 01:59 pm

Novartis struggling to win payer coverage for $2.1M gene therapy Zolgensma: analysts

Fierce Pharma

Wed, 07/3/19 - 10:38 am

In first 2020 debate, Democrats escalate their attacks on pharma and its high prices

Stat

Thu, 06/27/19 - 10:00 am

2020 Presidential election

pharma industry

It’s a big week for debates about drug prices, whether pharma likes it or not

Stat

Tue, 06/25/19 - 07:16 pm

Azar's Plan To Tie U.S. Drug Prices To Foreign Ones Will Impact Investments In R&D

Forbes

Fri, 06/21/19 - 09:42 am

Pharma CEOs didn’t show up for a congressional scolding, so progressives shadowboxed instead

Stat

Thu, 06/20/19 - 07:49 pm

pharma executives

What Bluebird Bio Gets Wrong In Pricing For Its $1.8 Million Drug

Forbes

Wed, 06/19/19 - 09:55 am

beta thalassemia

bluebird offers installment payments for Zynteglo gene therapy

Pharmaforum

Mon, 06/17/19 - 12:25 pm

outcome-based pricing

beta thalassemia

Is $1.8 Million for bluebird bio's New Gene Therapy Ridiculous?

Motley Fool

Sat, 06/15/19 - 05:49 pm

beta thalassemia

Bluebird sets $1.8M price tag for blood-disease gene therapy

Biopharma Dive

Fri, 06/14/19 - 12:08 pm

beta thalassemia

The top 10 most-expensive meds in the U.S.—and they're not the usual suspects

Fierce Pharma

Thu, 06/13/19 - 12:14 pm

Spark Therapeutics

Move Over, Martin Shkreli: This Pharma Exec Is Accused Of Fixing Prices On 107 Drugs

Forbes

Wed, 06/12/19 - 06:58 pm

Maureen Cavanaugh

Teva Pharmaceutical

price collusion

House progressives challenge drugmakers to come back to Capitol Hill

Stat

Wed, 06/12/19 - 06:52 pm

Gilead Sciences

How pharma could benefit from one of Congress’ signature drug pricing ideas

Stat

Tue, 06/11/19 - 09:33 am

From BIO meeting, Merck CEO Ken Frazier defends capitalism, drug industry

Biopharma Dive

Wed, 06/5/19 - 07:29 pm

Cheaper Versions of the Most Expensive Drugs May be Coming, but Monopolies Will Likely Remain

Motley Fool

Wed, 06/5/19 - 10:07 am

Here's Why Generic-Drug Manufacturers Lost As Much As 43.2% in May

Motley Fool

Wed, 06/5/19 - 09:38 am

Pages